FDA-Inspected Site

Transpire Bio Inc

2 FDA inspections are on record for Transpire Bio Inc in Weston, United States.

483· Form 483 issued

Weston, United States · Last updated July 12, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-11-07.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
3 Nov 2025 – 7 Nov 2025Human Drugs483On file
23 Sep 2025 – 1 Oct 2025Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

1 Oct 2025
21 CFR 211.182

Specific information required in individual logs

Cited by Jennifer Lalama, Mickell Smith

1 Oct 2025
21 CFR 211.192

Quality control unit review of records

Cited by Jennifer Lalama, Mickell Smith

1 Oct 2025
21 CFR 211.82(b)

Quarantine Storage of Components

Cited by Jennifer Lalama, Mickell Smith

Investigators

FDA investigators tied to this site in the record.

Yiyue C Zhang1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.82(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Transpire Bio Inc's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat